Genpact Limited 2022 Form 10-K Summary
Business context and reporting period
Genpact Limited is a Bermuda-incorporated global professional services company providing Digital Operations and Data-Tech-AI services, including business-process transformation, analytics, cloud, automation and artificial intelligence solutions. The filing covers the fiscal year ended December 31, 2022, rather than a standalone fourth quarter. Genpact had approximately 118,900 employees in more than 35 countries and served more than 800 clients.
Key financial metrics
| Metric | 2022 | 2021 | Change |
|---|---|---|---|
| Net revenue | $4,371.2 million | $4,022.2 million | Up 8.7%; 11.1% constant currency |
| Data-Tech-AI revenue | $1,959.9 million | $1,692.3 million | Up 15.8% |
| Digital Operations revenue | $2,411.3 million | $2,329.9 million | Up 3.5% |
| Gross profit | $1,536.4 million | $1,432.0 million | Up 7.3% |
| Gross margin | 35.1% | 35.6% | Down 50 basis points |
| Income from operations | $502.2 million | $509.0 million | Down 1.3% |
| Operating margin | 11.5% | 12.7% | Down 120 basis points |
| Net income | $353.4 million | $369.4 million | Down 4.3% |
| Diluted EPS | $1.88 | $1.91 | Down 1.6% |
| Adjusted income from operations | $718.2 million | $662.7 million | Up 8.4%; margin 16.5% in both years |
| Operating cash flow | $443.7 million | $694.3 million | Down 36.1% |
| Capital expenditures and internally generated intangibles | $54.4 million | $57.2 million | Lower year over year |
Revenue growth was led by Data-Tech-AI services, particularly cloud-based data and analytics solutions. Segment revenue growth was 16.5% in Financial Services, 7.7% in Consumer and Healthcare, and 11.7% in High Tech and Manufacturing. New bookings increased to $3.9 billion from $3.7 billion.
Cash and cash equivalents declined to $646.8 million from $899.5 million. Net accounts receivable increased to $994.8 million, reflecting higher days sales outstanding. No single client represented more than 10% of accounts receivable, but approximately 70% of revenue came from North American clients and more than 15% from European clients.
Total debt was $1.275 billion at year-end, including $528.4 million under the term loan, $398.9 million of 3.375% senior notes due December 2024, and $348.0 million of 1.75% senior notes due April 2026. Genpact also had $151.0 million of funded revolving borrowings. The company entered into a new unsecured $530 million term loan and $650 million revolving facility maturing December 2027. It was in compliance with its covenants, including net debt to EBITDA below 3x and interest coverage above 3x.
Material changes versus the prior comparable period
- Revenue increased, but reported operating income and net income declined because of wage inflation, talent replacement costs, higher travel and investment spending, restructuring charges and impairment charges.
- Gross margin declined to 35.1%; management attributed the pressure primarily to higher personnel expenses, wage inflation, talent replacement costs and travel costs, partly offset by pricing actions and improved Data-Tech-AI utilization.
- Operating cash flow fell substantially, principally because of increased investment in accounts receivable, higher days sales outstanding, higher tax payments, employee-related payments and customer acquisition costs.
- Genpact recorded $38.8 million of restructuring costs, including $17.1 million of employee severance and $21.7 million of primarily non-cash lease and asset charges.
- The company recorded a $32.6 million impairment charge related to a Consumer and Healthcare business classified as held for sale. The business generated $12.0 million of revenue and a $24.8 million loss from April 1 through December 31, 2022.
- Goodwill declined to $1.684 billion, primarily due to foreign-exchange effects and the held-for-sale classification. Management concluded that its reporting units did not require a broader goodwill impairment charge.
- Share repurchases totaled $214.0 million for 4.8 million shares. Quarterly dividends increased to $0.125 per share, or $0.50 annually, and the board approved a planned 2023 annual dividend of $0.55 per share.
Guidance, outlook, commentary, risks and unusual items
The filing does not provide a clear formal 2023 revenue or earnings guidance figure. Management expects cash from operations, cash reserves and debt capacity to fund operations, growth, dividends and potential repurchases for the next twelve months, but cautions that macroeconomic, inflationary, geopolitical and pandemic-related conditions could adversely affect cash flows.
Management is pursuing domain-led digital transformation, growth in Data-Tech-AI offerings, expansion in supply chain, sales and commercial, and risk services, and a flexible hybrid delivery model. Key operating pressures include elevated employee attrition, reported at 35% in 2022 versus a normalized historical range of 26% to 28%, competition for skilled talent, wage inflation, foreign-exchange volatility, client spending delays and long sales and implementation cycles.
Significant contingencies include Indian tax disputes. The filing describes approximately $229 million of aggregate demands from certain earlier assessment orders, of which $120 million had received favorable appellate outcomes and $109 million remained under appeal. In the first quarter of 2023, the Indian tax authorities issued an additional assessment of approximately $865 million related to a 2015 internal restructuring. Genpact has appealed these matters and recorded no reserve. The company also faces disputes regarding Indian GST and service-tax export exemptions involving approximately $28.1 million of denied or challenged refunds; no reserve was recorded after a favorable Punjab and Haryana High Court ruling, although further appeals remain possible.
Other important risks include cybersecurity and data-privacy breaches, dependence on India for delivery capacity, concentration in North America and Europe and certain industries, client concentration and former GE relationships, currency and interest-rate exposure, ERP implementation risk, regulatory changes affecting offshore outsourcing, and potential increases in Indian employee-benefit obligations. The company reported effective disclosure controls and internal control over financial reporting, and KPMG issued unqualified audit opinions.
Facts investors should verify
- Whether revenue growth and new bookings convert into sustained growth in operating income and cash flow.
- Progress in reducing employee attrition and offsetting wage inflation through pricing, productivity and utilization improvements.
- Days sales outstanding, collections and the resulting effect on operating cash flow and liquidity.
- Debt maturities, variable-rate exposure, covenant headroom and the availability of the revolving credit facility.
- Outcomes of the Indian tax assessments, GST and service-tax refund disputes, and any related interest, penalties or reserves.
- Execution of the hybrid delivery strategy, ERP implementation and the divestiture of the Consumer and Healthcare business.
- Future goodwill or intangible-asset impairments, restructuring charges and other items excluded from adjusted income from operations.
- Whether the planned $0.55 annual dividend and expanded $2.25 billion share-repurchase authorization remain consistent with cash generation and debt covenants.